Skip to content

Clinical trials

Phase 1/2 Attention Deficit Disorder with Hyperactivity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Phase: Phase 1/2 Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20071
20091
20102
20132
20182
20191
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status2
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AlkaliDx, Inc.1
Children's Hospital Medical Center, Cincinnati1
Cingulate Therapeutics1
CoMentis1
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.1
Ironshore Pharmaceuticals and Development, Inc1
National Institute of Mental Health (NIMH)1
New River Pharmaceuticals1
Obslap Research LLC1
Oregon Health and Science University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity14
Amphetamine-Related Disorders1
Asperger Syndrome1
Brain Injuries, Traumatic1
Cerebral Palsy1
Conduct Disorder1
Dyslexia1
Parasomnias1
Psychomotor Agitation1
Restless Legs Syndrome1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.